Access cutting-edge gastrointestinal cancer treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access gastrointestinal cancer specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastrointestinal cancer treatment provided free
The purpose of this study is to compare the efficacy of two study drugs, Avatrobopag versus placebo, to treat persistent Chemotherapy-Induced Thrombocytopenia (CIT) in patients with gastrointestinal (GI) malignancies receiving cytotoxic chemotherapy. The names of the study drugs involved in this study are: * Avatrombopag (a thrombopoietin receptor agonist) * Matching placebo
Sponsor: Hanny Al-Samkari, MD
Check if you qualify for this gastrointestinal cancer clinical trial in Portland, OR
If you're searching for gastrointestinal cancer treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastrointestinal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.